105 related articles for article (PubMed ID: 11937346)
1. A practical synthesis and biological evaluation of 9-halogenated PGF analogues.
Tani K; Naganawa A; Ishida A; Egashira H; Odagaki Y; Miyazaki T; Hasegawa T; Kawanaka Y; Sagawa K; Harada H; Ogawa M; Maruyama T; Nakai H; Ohuchida S; Kondo K; Toda M
Bioorg Med Chem; 2002 Jun; 10(6):1883-94. PubMed ID: 11937346
[TBL] [Abstract][Full Text] [Related]
2. Development of a highly selective EP2-receptor agonist. Part 2: identification of 16-hydroxy-17,17-trimethylene 9beta-chloro PGF derivatives.
Tani K; Naganawa A; Ishida A; Egashira H; Sagawa K; Harada H; Ogawa M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2002 Apr; 10(4):1107-14. PubMed ID: 11836121
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of a selective EP4-receptor agonist. Part 3: 16-phenyl-5-thiaPGE(1) and 9-beta-halo derivatives with improved stability.
Maruyama T; Asada M; Shiraishi T; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2002 Jun; 10(6):1743-59. PubMed ID: 11937333
[TBL] [Abstract][Full Text] [Related]
4. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
[TBL] [Abstract][Full Text] [Related]
5. Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives.
Tani K; Naganawa A; Ishida A; Sagawa K; Harada H; Ogawa M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2002 Apr; 10(4):1093-106. PubMed ID: 11836120
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies of 16-methoxy-16-methyl prostaglandins.
Guzzi U; Ciabatti R; Padova G; Battaglia F; Cellentani M; Depaoli A; Galliani G; Schiatti P; Spina G
J Med Chem; 1986 Oct; 29(10):1826-32. PubMed ID: 3761303
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of brain PGE2 and PGF2 alpha receptors and receptor-coupled second messengers by cyclooxygenase inhibition in newborn pigs.
Li DY; Varma DR; Chemtob S
J Pharmacol Exp Ther; 1995 Jan; 272(1):15-9. PubMed ID: 7815327
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture.
de Brum-Fernandes AJ; Morisset S; Bkaily G; Patry C
Br J Pharmacol; 1996 Aug; 118(7):1597-604. PubMed ID: 8842420
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis.
Soper DL; Milbank JB; Mieling GE; Dirr MJ; Kende AS; Cooper R; Jee WS; Yao W; Chen JL; Bodman M; Lundy MW; De B; Stella ME; Ebetino FH; Wang Y; deLong MA; Wos JA
J Med Chem; 2001 Nov; 44(24):4157-69. PubMed ID: 11708917
[TBL] [Abstract][Full Text] [Related]
10. Expression of prostaglandin receptors EP4 and FP in human lens epithelial cells.
Mukhopadhyay P; Bhattacherjee P; Andom T; Geoghegan TE; Andley UP; Paterson CA
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):105-12. PubMed ID: 9888433
[TBL] [Abstract][Full Text] [Related]
11. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antifertility activity of omega-chain phenyl- and 16-phenoxy-analogues of (+/-)-11-deoxyprostaglandin F1 alpha.
Broughton BJ; Caton MP; Coffee EC; Hambling DJ; Palfreyman MN; Withnall MT; Wooldridge KR
Prostaglandins; 1980 Apr; 19(4):559-75. PubMed ID: 7384556
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 10-oxa-11-deoxyprostaglandin E1 and 10-nor-9,11-secoprostaglandin F1 and their derivatives.
Carroll FI; Hauser FM; Huffman RC; Coleman MC
J Med Chem; 1978 Apr; 21(4):321-5. PubMed ID: 650661
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of a highly selective EP4-receptor agonist. Part 2: 5-thia and 9beta-haloPG derivatives with improved stability.
Maruyama T; Asada M; Shiraishi T; Sakata K; Seki A; Yoshida H; Shinagawa Y; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem Lett; 2001 Aug; 11(15):2033-5. PubMed ID: 11454474
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of carboxyl-terminus modified prostaglandin analogues.
Schaaf TK; Hess HJ
J Med Chem; 1979 Nov; 22(11):1340-6. PubMed ID: 533881
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of a selective EP4-receptor agonist. Part 1: discovery of 3,7-dithiaPGE1 derivatives and identification of their omega chains.
Maruyama T; Asada M; Shiraishi T; Egashira H; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2002 Apr; 10(4):975-88. PubMed ID: 11836107
[TBL] [Abstract][Full Text] [Related]
17. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
Regan JW; Bailey TJ; Pepperl DJ; Pierce KL; Bogardus AM; Donello JE; Fairbairn CE; Kedzie KM; Woodward DF; Gil DW
Mol Pharmacol; 1994 Aug; 46(2):213-20. PubMed ID: 8078484
[TBL] [Abstract][Full Text] [Related]
18. Luteolytic prostaglandins. Synthesis and biological activity.
Bartmann W; Beck G; Lerch U; Teufel H; Schölkens B
Prostaglandins; 1979 Feb; 17(2):301-11. PubMed ID: 441438
[TBL] [Abstract][Full Text] [Related]
19. C(14)-fluorinated prostaglandins: synthesis and biological evaluation of the methyl esters of (+)-14-fluoro-, (+)-15-epi-14-fluoro-, (+)-13(E)-14-fluror-, and (+)-13(E)-15-epi-14-fluoroprostaglandin F2 alpha.
Grieco PA; Schillinger WJ; Yokoyama Y
J Med Chem; 1980 Oct; 23(10):1077-83. PubMed ID: 7420352
[TBL] [Abstract][Full Text] [Related]
20. AL-3138 antagonizes FP prostanoid receptor-mediated inositol phosphates generation: comparison with some purported FP antagonists.
Sharif NA; Crider JY; Davis TL
J Pharm Pharmacol; 2000 Dec; 52(12):1529-39. PubMed ID: 11197083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
